Differences in daytime and nocturnal IOP identified

Article

The identified nocturnal differences in intraocular pressure (IOP) include reductions in aqueous flow, outflow facility and uveoscleral outflow, according to a study published in the Archives of Ophthalmology.

The identified nocturnal differences in intraocular pressure (IOP) include reductions in aqueous flow, outflow facility and uveoscleral outflow, according to a study published in the Archives of Ophthalmology.

Dr Hong Liu et al., Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA, studied 30 healthy participants. The measurements included IOP by pneumatonometry, aqueous flow by fluorophotometry, outflow facility by fluorophotometry and tonography, uveoscleral outflow by mathematical calculation, central cornea thickness by pachymetry, and blood pressure by sphygmomanometry. Each subject underwent 1 daytime visit and 1 nocturnal visit for the recording of aqueous humor dynamics.

The findings demonstrated that seated IOP was reduced by 16% when compared during the day and night. Nocturnal supine IOP increased by 17%. During the night, aqueous flow was reduced by 49% and fluorophotometric outflow facility was reduced by 45%. Uveoscleral outflow was lowered only when using tonographic outflow facility. All other measurements remained the same.

The results also suggested that nocturnal changes in IOP are influenced by the posture of the individual.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.